Sandbox E20

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (21:59, 20 January 2022) (edit) (undo)
 
(20 intermediate revisions not shown.)
Line 14: Line 14:
The X-ray structure shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE, to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE versus butyrylcholinesterase (BChE). It also delineates voids within the gorge that are not occupied by E2020 and could provide sites for potential modification of E2020 to produce drugs with improved pharmacological profiles.
The X-ray structure shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE, to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE versus butyrylcholinesterase (BChE). It also delineates voids within the gorge that are not occupied by E2020 and could provide sites for potential modification of E2020 to produce drugs with improved pharmacological profiles.
-
<scene name='90/902074/Contacts_near_e2020/1'>yyy</scene>
 
-
 
+
<scene name='90/902074/Cartoon_and_e20/1'>cartoon_and_E2020</scene>
-
<scene name='90/902074/Contact_e20/1'>xxx</scene>
+
<jmol>
<jmol>
Line 29: Line 27:
</jmolCheckbox>
</jmolCheckbox>
</jmol>
</jmol>
 +
 +
<scene name='90/902074/T/1'>residues near E2020</scene>
==About this Structure==
==About this Structure==

Current revision

PDB ID 1eve

Drag the structure with the mouse to rotate

Reference

Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:10368299

Personal tools